New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 9, 2012
16:13 EDTMDVNMedivation sees FY12 OpEx $205M-$215M
Medivation currently expects total operating expenses for 2012, net of cost-sharing payments from Astellas, to be between $205M-$215M, approximately $25M of which consists of non-cash stock-based compensation expense. This increase from prior guidance of between $183M-$198M is due primarily to increased compensation and royalty expense in 2012 resulting from XTANDI's approval in the U.S. approximately one quarter earlier than expected. Medivation continues to expect to incur approximately $15M in capital expenditures in 2012, primarily related to leasehold improvements at its new corporate and commercial headquarters facilities.
News For MDVN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 25, 2014
16:13 EDTMDVNMedivation to names Joseph Lobacki as Chief Commercial Officer
Subscribe for More Information
November 21, 2014
08:18 EDTMDVNMedivation management to meet with Deutsche Bank
Subscribe for More Information
November 20, 2014
08:14 EDTMDVNMedivation management to meet with UBS
Subscribe for More Information
November 19, 2014
07:09 EDTMDVNJefferies to hold a conference
2014 Global London Healthcare Conference is being held in London, England on November 19-20.
November 12, 2014
11:17 EDTMDVNLeerink major pharma & biotech analysts hold analyst/industry conference call
Subscribe for More Information
November 11, 2014
15:43 EDTMDVNLeerink major pharma & biotech analysts hold analyst/industry conference call
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use